Literature DB >> 26600969

Psychosocial impact of irritable bowel syndrome: A brief review.

Sarah Ballou1, Alyse Bedell1, Laurie Keefer1.   

Abstract

Irritable bowel syndrome (IBS) is a common disorder of the gastrointestinal tract with unclear etiology and no reliable biomarker. Like other chronic and functional disorders, medical treatments for IBS are suboptimal and the overall illness burden is high. Patients with IBS report high rates of psychopathology, low quality of life, and increased suicidal ideation. These patients also miss more days of work, are less productive at work, and use many healthcare resources. However, little is known about the burden of IBS on daily functioning. The primary aim of this paper is to review the current literature on the burden of IBS and to highlight the need for further research to evaluate the impact of IBS on daily activities. This research would contribute to our existing understanding of the impact of IBS on overall quality of life and well-being.

Entities:  

Keywords:  Biopsychosocial; Burden of illness; Daily activities; Irritable bowel syndrome; Quality of life

Year:  2015        PMID: 26600969      PMCID: PMC4644875          DOI: 10.4291/wjgp.v6.i4.120

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  30 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  The impact of functional gastrointestinal disorders on quality of life.

Authors:  N A Koloski; N J Talley; P M Boyce
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

Review 3.  Some unexplored regions of psychosomatic medicine.

Authors:  H Weiner
Journal:  Psychother Psychosom       Date:  1987       Impact factor: 17.659

Review 4.  Diagnosis and treatment of irritable bowel syndrome: state of the art.

Authors:  Kirsten Tillisch; Lin Chang
Journal:  Curr Gastroenterol Rep       Date:  2005-08

5.  Post-traumatic stress disorder and other co-morbidities in a sample population of patients with irritable bowel syndrome.

Authors:  Hagit Cohen; Alan Jotkowitz; Dan Buskila; Sharon Pelles-Avraham; Zeev Kaplan; Lily Neumann; Ami D Sperber
Journal:  Eur J Intern Med       Date:  2006-12       Impact factor: 4.487

6.  Meta-analysis: The treatment of irritable bowel syndrome.

Authors:  D Lesbros-Pantoflickova; P Michetti; M Fried; C Beglinger; A L Blum
Journal:  Aliment Pharmacol Ther       Date:  2004-12       Impact factor: 8.171

7.  Lower urinary tract symptoms in women with irritable bowel syndrome.

Authors:  Ya-Jun Guo; Chen-Hsun Ho; Shyh-Chyan Chen; Shun-Shuang Yang; Han-Mo Chiu; Kuo-How Huang
Journal:  Int J Urol       Date:  2010-01-19       Impact factor: 3.369

8.  A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.

Authors:  Philip M Boyce; Nicholas J Talley; Belinda Balaam; Natasha A Koloski; George Truman
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

9.  Irritable bowel syndrome in France: a common, debilitating and costly disorder.

Authors:  Michel Dapoigny; Jérôme Bellanger; Bruno Bonaz; Stanislas Bruley des Varannes; Lionel Bueno; Benoît Coffin; Philippe Ducrotté; Bernard Flourié; Marc Lémann; Anne Lepicard; Olivier Reigneau
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 2.566

Review 10.  Somatic comorbidities of irritable bowel syndrome: a systematic analysis.

Authors:  Andrea Riedl; Marco Schmidtmann; Andreas Stengel; Miriam Goebel; Anna-Sophia Wisser; Burghard F Klapp; Hubert Mönnikes
Journal:  J Psychosom Res       Date:  2008-04-28       Impact factor: 3.006

View more
  12 in total

1.  Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome.

Authors:  Kristen R Weaver; Gail D'Eramo Melkus; Jason Fletcher; Wendy A Henderson
Journal:  Biol Res Nurs       Date:  2018-02-05       Impact factor: 2.522

2.  Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial.

Authors:  Javad Mohamadi; Firoozeh Ghazanfari; Fazlollah Mir Drikvand
Journal:  Psychiatr Q       Date:  2019-09

3.  Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  Livia Guadagnoli; Ece A Mutlu; Bethany Doerfler; Ammoura Ibrahim; Darren Brenner; Tiffany H Taft
Journal:  Qual Life Res       Date:  2019-03-21       Impact factor: 4.147

4.  Neuronal-enriched extracellular vesicles in individuals with IBS: A pilot study of COMT and BDNF.

Authors:  Kristen R Weaver; Maja Mustapic; Dimitrios Kapogiannis; Wendy A Henderson
Journal:  Neurogastroenterol Motil       Date:  2021-09-09       Impact factor: 3.960

5.  Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan.

Authors:  Hitomi Kawanishi; Atsushi Sekiguchi; Misako Funaba; Yasushi Fujii; Kazuhiro Yoshiuchi; Hiroe Kikuchi; Keisuke Kawai; Kazushi Maruo; Norio Sugawara; Kenji Hatano; Tomotaka Shoji; Tadahiro Yamazaki; Kenta Toda; Masafumi Murakami; Masayasu Shoji; Chisato Ohara; Yoshitoshi Tomita; Shin Fukudo; Tetsuya Ando
Journal:  Biopsychosoc Med       Date:  2019-06-06

6.  Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial.

Authors:  Anca Trifan; Ovidiu Burta; Nicoleta Tiuca; Diana Corina Petrisor; Augustin Lenghel; Javier Santos
Journal:  United European Gastroenterol J       Date:  2019-07-03       Impact factor: 4.623

7.  Randomised clinical trial: exploratory phase 2 study of ONO-2952 in diarrhoea-predominant irritable bowel syndrome.

Authors:  W E Whitehead; K Duffy; J Sharpe; T Nabata; M Bruce
Journal:  Aliment Pharmacol Ther       Date:  2016-11-07       Impact factor: 8.171

8.  Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.

Authors:  Hans Törnblom; Richard Goosey; Gwen Wiseman; Stephen Baker; Anton Emmanuel
Journal:  United European Gastroenterol J       Date:  2018-07-09       Impact factor: 4.623

9.  Sex Hormones, BDNF, Leptin, and TGF-β1 in Females With IBS: A Pilot Investigation.

Authors:  Kristen R Weaver; Christina M Boulineaux; Jeffrey M Robinson; Kierra Butler; Margaret M Heitkemper; Wendy A Henderson
Journal:  Biol Res Nurs       Date:  2020-08-18       Impact factor: 2.522

10.  Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study.

Authors:  Kristen R Weaver; Gail D' Eramo Melkus; Jason Fletcher; Wendy A Henderson
Journal:  Nurs Res       Date:  2018 May/Jun       Impact factor: 2.381

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.